Overview
Partial deletion of the long arm of chromosome 5 syndrome (also referred to as 5q partial monosomy or 5q deletion syndrome in the constitutional context) encompasses a group of rare chromosomal disorders caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 5. Because the size and precise location of the deleted segment can vary considerably from patient to patient, the clinical presentation is highly variable. This condition is distinct from the acquired 5q- syndrome seen in myelodysplastic disorders; here the deletion is constitutional (present from birth) and affects multiple organ systems during development. Common clinical features may include intellectual disability of variable severity, developmental delay, growth retardation, distinctive craniofacial features (such as microcephaly, low-set ears, broad or flat nasal bridge, and micrognathia), and musculoskeletal anomalies. Congenital heart defects, feeding difficulties in infancy, and hypotonia have also been reported in some individuals. The specific combination and severity of symptoms depend on which genes are encompassed by the deleted region. Some patients may have relatively mild manifestations if the deletion is small, while larger deletions tend to produce more complex phenotypes involving multiple body systems including the central nervous system, cardiovascular system, and skeletal system. There is no cure for this chromosomal condition. Management is supportive and symptom-based, typically involving a multidisciplinary team of specialists. Early intervention programs including speech therapy, physical therapy, and occupational therapy are important for optimizing developmental outcomes. Cardiac anomalies, if present, may require surgical correction. Genetic counseling is recommended for affected families to assess recurrence risk, which depends on whether the deletion arose de novo or was inherited from a parent carrying a balanced chromosomal rearrangement.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Partial deletion of the long arm of chromosome 5 syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Partial deletion of the long arm of chromosome 5 syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Partial deletion of the long arm of chromosome 5 syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Partial deletion of the long arm of chromosome 5 syndrome.
Community
No community posts yet. Be the first to share your experience with Partial deletion of the long arm of chromosome 5 syndrome.
Start the conversation →Latest news about Partial deletion of the long arm of chromosome 5 syndrome
No recent news articles for Partial deletion of the long arm of chromosome 5 syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Partial deletion of the long arm of chromosome 5 syndrome
What is Partial deletion of the long arm of chromosome 5 syndrome?
Partial deletion of the long arm of chromosome 5 syndrome (also referred to as 5q partial monosomy or 5q deletion syndrome in the constitutional context) encompasses a group of rare chromosomal disorders caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 5. Because the size and precise location of the deleted segment can vary considerably from patient to patient, the clinical presentation is highly variable. This condition is distinct from the acquired 5q- syndrome seen in myelodysplastic disorders; here the deletion is constitutional (present from birt
At what age does Partial deletion of the long arm of chromosome 5 syndrome typically begin?
Typical onset of Partial deletion of the long arm of chromosome 5 syndrome is neonatal. Age of onset can vary across affected individuals.